About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Chicago | 177 Studies

Clinical Trials DepressionChicago

Depression Clinical Trials in Chicago

Find 177 clinical trials for depression near Chicago, Illinois. Connect with research centers in your area.

All Depression trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-177 of 177 trials

TerminatedA Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepressant (selective serotonin…NCT05518149·Birmingham, Alabama and 233 others

Depression Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

SuspendedPramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVA phase II, randomized, open-label, two-arm clinical trial evaluating the safety and efficacy of pramipexole extended release (ER) versus escitalopram for the treatment of major…NCT06705478·Birmingham, Alabama and 40 others

CompletedGoal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderThe purpose of this study is to determine the effectiveness of treatment with vortioxetine on participant goal achievement after a change in antidepressant medication for the…NCT02972632·Costa Mesa, California and 24 others

CompletedThe Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionThe purposes of this study are to determine: * Whether olanzapine plus fluoxetine in combination will help patients with treatment-resistant major depression.NCT00035321·Oceanside, California and 32 others

CompletedEffectiveness of a Mobile Texting Intervention for People With Serious Mental IllnessTesting an mHealth mobile interventionist texting program on illness management.NCT03062267·Chicago, Illinois and 1 other

TerminatedPostpartum Depression: Transdermal Estradiol Versus SertralineThe purpose of this study is to determine whether estrogen patches are effective for the treatment of postpartum major depression, as compared to sertraline (Zoloft) and placebo.NCT00744328·Chicago, Illinois

CompletedExploring a Potential Blood Test to Diagnose Major Depressive DisorderThe purpose of this study is to develop a blood test for major depression and measure the effects of ziprasidone monotherapy on these markers.NCT00705185·Farmington, Connecticut and 4 others

CompletedQuetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderThe purpose of this study is to determine safety \& efficacy of SEROQUEL SR™ in the treatment of major depressive disorder compared to placebo \& to evaluate quality of sleep…NCT00278941·Birmingham, Alabama and 167 others

CompletedA Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant TreatmentThe current study will evaluate the antidepressant effect of CERC-301 during 28 days of treatment in subjects with MDD who are currently experiencing a severe depressive episode…NCT01941043·Birmingham, Alabama and 23 others

CompletedStudy Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyThe purpose of this trial is to evaluate the efficacy and safety of risperidone versus placebo in subjects with Major Depressive Disorder with sub-optimal response to…NCT00095134·Birmingham, Alabama and 69 others

CompletedSafety Study of F2695 SR in Major Depressive DisorderThe purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.NCT01034267·Dothan, Alabama and 67 others

CompletedRelapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive DisorderThe purpose of this study is to evaluate the safety and efficacy of Levomilnacipran ER relative to placebo in the prevention of depression relapse in patients with major…NCT01085812·Beverly Hills, California and 34 others

WithdrawnInternet Intervention for the Prevention of Depression - Approaches to Improving MoodThis study will develop and evaluate the effectiveness of a technology-assisted behavioral intervention, consisting of Internet-based cognitive behavioral therapy combined with…NCT01080105·Chicago, Illinois

RecruitingA Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsThis is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive…NCT06223880·Bellflower, California and 39 others

CompletedGenecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDDIn this randomized clinical trial, subjects will be assigned to either an assay-guided treatment condition (AGT) or a treatment-as-usual condition (TAU).NCT02634177·Birmingham, Alabama and 22 others

CompletedTreatment for Adolescents With Depression Study (TADS)TADS is designed to compare the effectiveness of established treatments for teenagers suffering from major depressive disorder (MDD).NCT00006286·Chicago, Illinois and 11 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and InsomniaThis study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult participants with comorbid…NCT03771664·Little Rock, Arkansas and 27 others

PreviousPage 9 of 9

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia